Provided by Tiger Trade Technology Pte. Ltd.

CERo Therapeutics Holdings, Inc.

0.0466
+0.00214.72%
Volume:161.58K
Turnover:7.45K
Market Cap:983.39K
PE:0.00
High:0.0480
Open:0.0445
Low:0.0415
Close:0.0445
52wk High:42.00
52wk Low:0.0366
Shares:21.10M
Float Shares:1.76M
Volume Ratio:0.86
T/O Rate:9.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-98.7052
EPS(LYR):-434.4641
ROE:--
ROA:-210.22%
PB:-0.07
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
CERo Therapeutics Holdings, Inc.
Exchange:
OTCQB
Establishment Date:
2021
Employees:
8
Office Location:
201 Haskins Way,Suite 230,South San Francisco,California,United States
Zip Code:
94080
Fax:
- -
Introduction:
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.